You need to login...
If you are not registered...
| Subscribe to Krixos Health: | |
|
or call us on: +43 (0)1 27 63 015 or email: subscribe@krixos.com |
|
Most viewed
- 1. ImmunoGenesis doses first subject in Phase I/II trial of hypoxia reversal agent
- 2. Non-coding RNAs: emerging biomarkers and therapeutic targets in cancer and inflammatory diseases
- 3. Chronic stress and obesity work together to accelerate pancreatic cancer development and growth, study finds
- 4. Walking, moving more may lower risk of cardiovascular death for women with cancer history
- 5. Oncomicrobial vaccines mitigate tumor progression via precisely targeting oncomicrobes in mice
- 6. Eating one type of fruit could lower depression risk, study shows
- 7. Why the Global Cancer Market Could Surpass $900 Billion--And the Stocks Leading the Charge
- 8. Breast Lesion Localization Market is expected to generate a revenue of USD 560.17 Million by 2032, Globally, at 5.9% CAGR: Verified Market Research®
- 9. Clinical outcomes and aesthetic results of reverse sequence endoscopic versus traditional bilateral nipple-sparing mastectomy with immediate implant-based breast reconstruction-an analysis of initial 116 patients from single institution
- 10. Antibody conjugates in neuroblastoma: a step forward in precision medicine
Last updated at 4:34 GMT
Hot News Makers
Health/Pharma Companies
-
37601.72
-
25131.95
-
23410.05
-
22820.97
-
20530.43
-
14796.67
-
10496.92
-
8585.57
-
8535.74
-
7703.99
Drugs, Treatments, Trials
-
9225.08
-
8715.47
-
6692.56
-
5526.01
-
5283.08
-
4516.32
-
4154.76
-
4005.24
-
3447.58
-
2774.89
Last updated at 4:10 GMT
